A new antibody drug by pharmaceutical company inflaRx received FDA emergency use authorization to treat critically ill Covid-19 patients. One of the greatest hurdles for monoclonal antibody ...
A study conducted at the University of Helsinki under the direction of Docent Taru Meri uncovered a mechanism by which Borrelia bacteria are able to evade human immune defenses. The mechanism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results